Evidence map›Paper›PMID 31553050›Full record

ArticleBrain : a journal of neurology2019

Excitatory GABAergic signalling is associated with benzodiazepine resistance in status epilepticus.

Richard J Burman, Joshua S Selfe, John Hamin Lee, Maurits van den Berg, Alexandru Calin, Neela K Codadu, Rebecca Wright, Sarah E Newey, R Ryley Parrish, Arieh A Katz and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Brain : a journal of neurology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 55 papers.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 113 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Calcium-Activated Potassium Channel KMolecular neurobiology · 2025
    Article
  7. Article
  8. Review
  9. Pathophysiology of Status Epilepticus Revisited.International journal of molecular sciences · 2025
    Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Cognition in pediatric patients with diagnosis of epilepsyRevista medica del Instituto Mexicano del Seguro Social · 2024
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 3 institutions in 2 countries.

Richard J BurmanDivision of Cell Biology, Department of Human Biology, Neuroscience Institute and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Joshua S SelfeDivision of Cell Biology, Department of Human Biology, Neuroscience Institute and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
John Hamin LeeDivision of Cell Biology, Department of Human Biology, Neuroscience Institute and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Maurits van den BergDivision of Cell Biology, Department of Human Biology, Neuroscience Institute and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Alexandru CalinDepartment of Pharmacology, University of Oxford, Oxford, UK.
Neela K CodaduInstitute of Neuroscience, Medical School, Framlington Place, Newcastle upon Tyne, NE24HH, UK.
Rebecca WrightDepartment of Pharmacology, University of Oxford, Oxford, UK.
Sarah E NeweyDepartment of Pharmacology, University of Oxford, Oxford, UK.
R Ryley ParrishInstitute of Neuroscience, Medical School, Framlington Place, Newcastle upon Tyne, NE24HH, UK.
Arieh A KatzDivision of Medical Biochemistry, Department of Integrated Biomedical Sciences and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
Jo M WilmshurstDepartment of Paediatric Neurology, Red Cross War Memorial Children's Hospital, Neuroscience Institute, University of Cape Town, Cape Town, South Africa.
Colin J AkermanDepartment of Pharmacology, University of Oxford, Oxford, UK.
Andrew J TrevelyanInstitute of Neuroscience, Medical School, Framlington Place, Newcastle upon Tyne, NE24HH, UK.
Joseph V RaimondoDivision of Cell Biology, Department of Human Biology, Neuroscience Institute and Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town, South Africa.
University of Cape Town · ZAUniversity of Oxford · GBThe Neurosciences Foundation · GB

Funding

Medical Research Council MR/J013250/1Medical Research Council MR/R005427/1Wellcome Trust
6 · The paper itself

Abstract

Status epilepticus is defined as a state of unrelenting seizure activity. Generalized convulsive status epilepticus is associated with a rapidly rising mortality rate, and thus constitutes a medical emergency. Benzodiazepines, which act as positive modulators of chloride (Cl-) permeable GABAA receptors, are indicated as first-line treatment, but this is ineffective in many cases. We found that 48% of children presenting with status epilepticus were unresponsive to benzodiazepine treatment, and critically, that the duration of status epilepticus at the time of treatment is an important predictor of non-responsiveness. We therefore investigated the cellular mechanisms that underlie acquired benzodiazepine resistance, using rodent organotypic and acute brain slices. Removing Mg2+ ions leads to an evolving pattern of epileptiform activity, and eventually to a persistent state of repetitive discharges that strongly resembles clinical EEG recordings of status epilepticus. We found that diazepam loses its antiseizure efficacy and conversely exacerbates epileptiform activity during this stage of status epilepticus-like activity. Interestingly, a low concentration of the barbiturate phenobarbital had a similar exacerbating effect on status epilepticus-like activity, while a high concentration of phenobarbital was effective at reducing or preventing epileptiform discharges. We then show that the persistent status epilepticus-like activity is associated with a reduction in GABAA receptor conductance and Cl- extrusion capability. We explored the effect on intraneuronal Cl- using both gramicidin, perforated-patch clamp recordings and Cl- imaging. This showed that during status epilepticus-like activity, reduced Cl- extrusion capacity was further exacerbated by activity-dependent Cl- loading, resulting in a persistently high intraneuronal Cl-. Consistent with these results, we found that optogenetic stimulation of GABAergic interneurons in the status epilepticus-like state, actually enhanced epileptiform activity in a GABAAR dependent manner. Together our findings describe a novel potential mechanism underlying benzodiazepine-resistant status epilepticus, with relevance to how this life-threatening condition should be managed in the clinic.

Indexed as

Excitatory Amino Acidsgamma-Aminobutyric AcidSignal TransductionAnimalsAnticonvulsantsBenzodiazepinesChild, PreschoolDiazepamDrug ResistanceDrug Resistant EpilepsyEpilepsyHumansInfantMiceMice, Inbred C57BLPatch-Clamp TechniquesAnticonvulsantsBenzodiazepinesDiazepamExcitatory Amino Acidsgamma-Aminobutyric AcidPhenobarbitalReceptors, GABA-AchlorideGABAA receptorsinhibitionseizuresstatus epilepticus

Identifiers

PMID31553050
PMCPMC6904319
OpenAlexW2976031621

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.